일동제약 / 2022.03.17 사업보고서
1. 요약재무정보
가. 연결기준
(단위 : 원)
구분
제6기
제5기
제4기
(2021 12월말)
(2020 12월말)
(2019 12월말)
[유동자산]
301,550,000,000,000
233,243,000,000,000
233,367,000,000,000
ㆍ현금및현금성자산
135,586,000,000,000
85,564,000,000,000
89,959,000,000,000
자산총계
708,970,000,000,000
605,277,000,000,000
612,723,000,000,000
[유동부채]
364,141,000,000,000
185,010,000,000,000
211,843,000,000,000
[비유동부채]
184,245,000,000,000
165,719,000,000,000
147,989,000,000,000
부채총계
548,386,000,000,000
350,730,000,000,000
359,831,000,000,000
[자본금]
23,803,000,000,000
23,803,000,000,000
22,670,000,000,000
[이익잉여금]
△81,951,000,000,000
14,856,000,000,000
△4,872,000,000,000
[비지배지분]
7,676,000,000,000
-
-
자본총계
160,585,000,000,000
254,547,000,000,000
252,892,000,000,000
(2021.1.1~ 2021.12.31)
(2020.1.1~ 2020.12.31)
(2019.1.1~ 2019.12.31)
매출액
560,132,000,000,000
561,845,000,000,000
517,468,000,000,000
영업이익
△55,535,000,000,000
6,633,000,000,000
△1,373,000,000,000
당기순이익
△100,968,000,000,000
△13,019,000,000,000
△13,444,000,000,000
총포괄손익
△103,566,000,000,000
1,668,000,000,000
△15,228,000,000,000
주당순이익
△4,192
△547
△593
연결에 포함된 회사수
3
2
2